Literature DB >> 15905704

Association between Toll-like receptor 4 and inflammatory bowel disease.

Liekele E Oostenbrug1, Joost P H Drenth, Dirk J de Jong, Ilja M Nolte, Elvira Oosterom, Hendrik M van Dullemen, Klaas van der Linde, Gerard J te Meerman, Gerrit van der Steege, Jan H Kleibeuker, Peter L M Jansen.   

Abstract

BACKGROUND: The human Toll-like receptor 4 (TLR4) participates in the innate response. Recently, the TLR4 variant Asp299Gly has been described to affect the response of this receptor to lipopolysaccharide. As such, there is a potentially important role of TLR4 in the pathogenesis of inflammatory bowel disease (IBD). We studied the involvement of TLR4 in IBD in a large population of Dutch patients with IBD and in family-based controls.
METHODS: In 781 IBD cases and 315 controls, genotyping was performed forAsp299Gly and Thr399Ile variants and for 4 microsatellite markers flanking TLR4. Association analysis and the were applied. In addition, interaction of TLR4 with the caspase recruitment domain containing protein 15 gene (CARD15) was studied in patients with Crohn's disease (CD).
RESULTS: The haplotype sharing statistic showed association at microsatellite marker D9S1864 with IBD (P = 0.0019), and in particular with CD (P = 0.0025) and at TLR406 with ulcerative colitis (UC; P = 0.027). No association was found for Asp299Gly and Thr399Ile. However, the frequencies of both variant allele carriers were higher among CD cases with a disease onset > or = 40 years than among controls. No evidence for interaction between TLR4 and CARD15 was found.
CONCLUSIONS: Haplotype analysis shows that TLR4 is associated with both CD and UC. The Asp299Gly and Thr399Ile variants do not show an association with CD, UC, or IBD as a group, indicating that these polymorphisms are likely not the causal ones. We propose that the 2 polymorphisms are in linkage with (the) disease susceptibility variant(s) located elsewhere on TLR4.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905704     DOI: 10.1097/01.mib.0000161305.81198.0f

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  38 in total

Review 1.  Novel susceptibility genes in inflammatory bowel disease.

Authors:  Colin Noble; Elaine Nimmo; Daniel Gaya; Richard K Russell; Jack Satsangi
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

2.  Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.

Authors:  A Grabig; D Paclik; C Guzy; A Dankof; D C Baumgart; J Erckenbrecht; B Raupach; U Sonnenborn; J Eckert; R R Schumann; B Wiedenmann; A U Dignass; A Sturm
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli.

Authors:  M M Heimesaat; A Fischer; H-K Jahn; J Niebergall; M Freudenberg; M Blaut; O Liesenfeld; R R Schumann; U B Göbel; S Bereswill
Journal:  Gut       Date:  2007-01-25       Impact factor: 23.059

4.  Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis.

Authors:  Fabio Alessandro Facchini; Davide Di Fusco; Simona Barresi; Andrea Luraghi; Alberto Minotti; Francesca Granucci; Giovanni Monteleone; Francesco Peri; Ivan Monteleone
Journal:  Eur J Clin Pharmacol       Date:  2020-01-25       Impact factor: 2.953

5.  Common NOD2/CARD15 and TLR4 Polymorphisms Are Associated with Crohn's Disease Phenotypes in Southeastern Brazilians.

Authors:  Yolanda F M Tolentino; Paula Peruzzi Elia; Homero Soares Fogaça; Antonio José V Carneiro; Cyrla Zaltman; Rodrigo Moura-Neto; Ronir Raggio Luiz; Maria da Gloria C Carvalho; Heitor S de Souza
Journal:  Dig Dis Sci       Date:  2016-04-23       Impact factor: 3.199

Review 6.  Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease.

Authors:  Noah P Zimmerman; Rebecca A Vongsa; Michael K Wendt; Michael B Dwinell
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

7.  TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells.

Authors:  Diana M Lim; Sneha Narasimhan; Carmen Z Michaylira; Mei-Lun Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-24       Impact factor: 4.052

Review 8.  Inflammatory bowel disease: genetic and epidemiologic considerations.

Authors:  Judy H Cho
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

9.  Tolllike receptor 4 (TLR4) polymorphisms in Tunisian patients with Crohn's disease: genotype-phenotype correlation.

Authors:  Lilia Zouiten-Mekki; Maher Kharrat; Sami Karoui; Mariem Serghimi; Monia Fekih; Samira Matri; Lamia Kallel; Jalel Boubaker; Azza Filali; Habiba Chaabouni
Journal:  BMC Gastroenterol       Date:  2009-08-07       Impact factor: 3.067

10.  A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.

Authors:  Ryan Ungaro; Masayuki Fukata; David Hsu; Yasmin Hernandez; Keith Breglio; Anli Chen; Ruliang Xu; John Sotolongo; Cecillia Espana; Julia Zaias; Greg Elson; Lloyd Mayer; Marie Kosco-Vilbois; Maria T Abreu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.